Trial Profile
Phase II, Randomized, Double Blind, Placebo-Controlled Trial of Azithromycin in Patients With CF, Chronically Infected With Burkhoderia Cepacia Complex.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Azithromycin (Primary)
- Indications Burkholderia cepacia infections
- Focus Therapeutic Use
- 01 Aug 2009 New trial record